This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Cellink LLC for preventive maintenance, emergency service, support, and coverage for a government-owned Cellink I-DOT One dispensing system (S/N: I2-211089). The contract has a total ceiling value of $62,464.50 and a period of performance from June 1, 2022 to June 2, 2025, with no...
This is a $24,999.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment and reagents. The contract is for the delivery of unspecified laboratory equipment, with a period of performance through September 7, 2024. While not awarded under a set-aside program, Miltenyi Biotec has extensive...
This is a firm fixed price service agreement awarded by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $3,318.78 contract does not have a set-aside designation. It is a call order under an Indefinite Delivery Vehicle (IDV) with the NCI, which streamlines the agency's ability to order laboratory equipment maintenance, genetic...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (NIH NCI) awarded a $162,925.72 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit organization, for the procurement of a 3-Laser Attune CytPix Cytometer with CytKickMAX premium autosampler. This specialized flow cytometer instrument will be used by the NCI's Surgery Branch Flow Cytometer core facility to support ongoing cancer research, including DNA cell cycle...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (DHHS). The $93,067.38 contract is for the procurement of one QIAGEN QIASYMPHONY SP System. This automated DNA/RNA extraction system will support the NCI's Cancer Center for Research (CCR) Laboratory of Pathology in processing tissue, blood, and other samples for cancer research and diagnostics. The contract...
This firm fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to 10X Genomics, Inc., a life sciences technology company. The $89,216.00 contract provides 10X Genomics' Chromium Controller system and reagent kit to enable NCI researchers to perform single-cell RNA sequencing and T-cell receptor sequencing. This sole-source acquisition was conducted under simplified acquisition procedures for commercial items,...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) to Takara Bio USA, Inc. The contract is for the SMARTER ICELL8 CX SINGLE-CELL SYSTEM, which is a specialized instrument and reagents for generating next-generation sequencing (NGS) libraries from single cells, including tumor-specific T-cell receptor clonotypes. The $170,100.00 contract supports the NCI's Cancer Center...
This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Cellink LLC, a foreign-owned for-profit biotech company based in Germany. The $85,489.00 contract is for the procurement of a BIONOVA X 3D bioprinter and associated software, bioink, warranty, and installation/training services. This requirement was a streamlined solicitation for commercial items with...
This is a $14,390.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH-NCI) to Intera Oncology Inc., a for-profit organization, to provide laboratory supplies in support of cancer research efforts. The contract does not have a set-aside designation and was awarded directly to Intera Oncology Inc. as the prime contractor, with no mention of subcontractors. The purchase order includes the...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed-price purchase order valued at $24,940 to Global Life Sciences Solutions USA LLC. The contract calls for the delivery of an imaging system and associated easy-to-use software for band analysis and quantification of protein and DNA gels. The products and services will support research activities across the Laboratory of Biochemistry and...
This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $95,509.00, is for the procurement of one (1) I-DOT 2.0 dispensing system for the preparation of next-generation sequencing (NGS) library preps of T-cell receptors (TCRs) in support of cancer research. The contract was set aside for small businesses, and the prime contractor is Cellink LLC, a foreign-owned, for-profit biotech company headquartered in Germany with a registered presence in the United States. The contract includes delivery, installation, training, and warranty for the specialized scientific equipment.